“… 5 , 6 , 7 The prevalence of CHB among immigrant people living in the U.S. is approximately 3.1 %, with prevalence rates ranging from 4.5 % among people from Oceania, to 5.9 % among people from Asia and 8.6 % among people from Africa. 4 Furthermore, immigrant communities have increased risk of progression to HCC, 8 , 9 , 10 , 11 , 12 and increased rates of premature mortality attributed to CHB-related HCC compared to the non-Hispanic white population in the U.S. 13 , 14 Despite the negative health impacts of CHB and HCC within immigrant groups in the U.S., screening and vaccination rates remain suboptimal, 15 , 16 , 17 , 18 and fewer than 30 % of individuals who are living with CHB are aware of their status. 5 …”